Non-toxicity of Plant Candicidal Peptides for Mammalian Cell Lines and Galleria mellonella Model to Improving Selectivity for Clinical Use
Abstract Antimicrobial peptides (AMPs) are promising candidates for the development of new drugs. However, thorough studies on the toxicity of these molecules are scarce, which is a gap, as host toxicity is one of the main reasons for nonapproval of the drug by regulatory agencies. This work aimed to evaluate the toxicity of three AMPs isolated from Capsicum annuum leaves, named CaCPin-II, CaCDef-like and CaCLTP2. The AMP toxicological profile was evaluated by in vitro cytotoxicity against mammalian cells and systemic in vivo toxicity using Galleria mellonella larvae as study model. AMP cytotoxicity was evaluated in a broad panel of human cell lines, namely, vascular endothelium, cervical adenocarcinoma, prostatic epithelium, mammary epithelium and fibroblasts, and in murine macrophages. Cell viability was evaluated through metabolic activity, a gold standard method for assessing viability due to the speed, robustness and reliability of the results. To elucidate the toxicity mechanism of the peptides, their ability to bind to the cell surface and to permeabilize membranes was evaluated by measuring the zeta potential and the absorption of the SYTOX® Green fluorescent probe, respectively. The AMPs did not decrease cell viability or permeabilize the membranes of the cell lines at the tested concentrations. Only CaCLTP2 had the ability to interact with the cell surface, but it was not able to permeabilize them. The in vivo systemic toxicity was evaluated by the survival rate of the G. mellonella larvae inoculated with peptides. CaCPin-II showed in vivo toxicity, as the larval survival rate after the test was 60% lower than that of the controls. The results suggest that these peptides have potential as antimicrobial agents because they have low or no toxicity to mammalian cells and can serve as a framework for drug development..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
International journal of peptide research and therapeutics - 30(2024), 3 vom: 12. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cherene, Milena Bellei [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Bioactive peptides |
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s10989-024-10607-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR05549806X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR05549806X | ||
| 003 | DE-627 | ||
| 005 | 20240413064655.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240413s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10989-024-10607-9 |2 doi | |
| 035 | |a (DE-627)SPR05549806X | ||
| 035 | |a (SPR)s10989-024-10607-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |q VZ |
| 084 | |a 35.76 |2 bkl | ||
| 100 | 1 | |a Cherene, Milena Bellei |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Non-toxicity of Plant Candicidal Peptides for Mammalian Cell Lines and Galleria mellonella Model to Improving Selectivity for Clinical Use |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract Antimicrobial peptides (AMPs) are promising candidates for the development of new drugs. However, thorough studies on the toxicity of these molecules are scarce, which is a gap, as host toxicity is one of the main reasons for nonapproval of the drug by regulatory agencies. This work aimed to evaluate the toxicity of three AMPs isolated from Capsicum annuum leaves, named CaCPin-II, CaCDef-like and CaCLTP2. The AMP toxicological profile was evaluated by in vitro cytotoxicity against mammalian cells and systemic in vivo toxicity using Galleria mellonella larvae as study model. AMP cytotoxicity was evaluated in a broad panel of human cell lines, namely, vascular endothelium, cervical adenocarcinoma, prostatic epithelium, mammary epithelium and fibroblasts, and in murine macrophages. Cell viability was evaluated through metabolic activity, a gold standard method for assessing viability due to the speed, robustness and reliability of the results. To elucidate the toxicity mechanism of the peptides, their ability to bind to the cell surface and to permeabilize membranes was evaluated by measuring the zeta potential and the absorption of the SYTOX® Green fluorescent probe, respectively. The AMPs did not decrease cell viability or permeabilize the membranes of the cell lines at the tested concentrations. Only CaCLTP2 had the ability to interact with the cell surface, but it was not able to permeabilize them. The in vivo systemic toxicity was evaluated by the survival rate of the G. mellonella larvae inoculated with peptides. CaCPin-II showed in vivo toxicity, as the larval survival rate after the test was 60% lower than that of the controls. The results suggest that these peptides have potential as antimicrobial agents because they have low or no toxicity to mammalian cells and can serve as a framework for drug development. | ||
| 650 | 4 | |a Bioactive peptides |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cytotoxicity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Drug development |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a In vivo toxicity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Preclinical trials |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Cavaco, Marco Calvinho |e verfasserin |4 aut | |
| 700 | 1 | |a Neves, Vera Luisa Santos |e verfasserin |4 aut | |
| 700 | 1 | |a Castanho, Miguel Augusto Rico Botas |e verfasserin |4 aut | |
| 700 | 1 | |a Taveira, Gabriel Bonan |e verfasserin |4 aut | |
| 700 | 1 | |a Guimarães, Thomas Zacarone Afonso |e verfasserin |4 aut | |
| 700 | 1 | |a de Oliveira Carvalho, André |e verfasserin |4 aut | |
| 700 | 1 | |a de Oliveira Mello, Erica |e verfasserin |4 aut | |
| 700 | 1 | |a de Azevedo dos Santos, Layrana |e verfasserin |4 aut | |
| 700 | 1 | |a Gomes, Valdirene Moreira |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of peptide research and therapeutics |d Springer Netherlands, 2005 |g 30(2024), 3 vom: 12. Apr. |h Online-Ressource |w (DE-627)SPR05509161X |w (DE-600)2192632-3 |w (DE-576)254902375 |x 1573-3904 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2024 |g number:3 |g day:12 |g month:04 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10989-024-10607-9 |m X:VERLAG |x 0 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.76 |j Aminosäuren |j Peptide |j Eiweiße |x Biochemie |q VZ |
| 951 | |a AR | ||
| 952 | |d 30 |j 2024 |e 3 |b 12 |c 04 | ||